Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H28N3O.Cl |
| Molecular Weight | 397.941 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CCN(CC)CC[N+]1=CC2=C(C)C3=C(NC4=C3C=C(O)C=C4)C(C)=C2C=C1
InChI
InChIKey=UCICRVXYPSKKJK-UHFFFAOYSA-N
InChI=1S/C23H27N3O.ClH/c1-5-25(6-2)11-12-26-10-9-18-16(4)23-22(15(3)20(18)14-26)19-13-17(27)7-8-21(19)24-23;/h7-10,13-14,27H,5-6,11-12H2,1-4H3;1H
| Molecular Formula | C23H27N3O |
| Molecular Weight | 361.48 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Datelliptium is a DNA-intercalating agent, an analog of a natural alkaloid ellipticine. The compound was active in vivo against a variety of murine solid tumors. In a phase I clinical trial no objective complete or partial responses were observed in patients with solid tumors or lymphoma treated with datelliptium.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:23:30 GMT 2025
by
admin
on
Mon Mar 31 18:23:30 GMT 2025
|
| Record UNII |
V5QKF7Q20O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C582
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C060073
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
5983
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
DTXSID80909340
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
C76759
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
CHEMBL197585
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
105118-14-7
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
72034
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
100000083444
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
SUB06916MIG
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY | |||
|
V5QKF7Q20O
Created by
admin on Mon Mar 31 18:23:30 GMT 2025 , Edited by admin on Mon Mar 31 18:23:30 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |